×
Novo Integrated Sciences Share Holder Equity 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novo Integrated Sciences share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
View More
Novo Integrated Sciences Share Holder Equity 2012-2024 | NVOS
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Novo Integrated Sciences share holder equity from 2012 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Related Stocks
Company Name
Market
Cap
Fresenius SE (FSNUY)
$21.4B
Quest Diagnostics (DGX)
$18.2B
DaVita (DVA)
$14.4B
Encompass Health (EHC)
$10B
Chemed (CHE)
$8.5B
Elanco Animal Health (ELAN)
$5.9B
Option Care Health (OPCH)
$5.3B
RadNet (RDNT)
$4.8B
LifeStance Health (LFST)
$3B
Amedisys (AMED)
$3B
Addus HomeCare (ADUS)
$2.3B
Astrana Health (ASTH)
$2.1B
U.S Physical Therapy (USPH)
$1.3B
Pennant (PNTG)
$909M
Aveanna Healthcare Holdings (AVAH)
$889M
Atai Life Sciences (ATAI)
$260M
Bioqual (BIOQ)
$55M
Daxor (DXR)
$37M
Ontrak (OTRK)
$7M
MEDIROM Healthcare Technologies (MRM)
$5M
IMAC Holdings (BACK)
$1M
Psychemedics (PMD)
$0M